allergic rhinitis articles & resources on Made-in-China.com

Choose The Most Appropriate Flooring Solution

Dec 5, 2014

House decor is a very personal topic. Each family has its own tastes and priorities when it comes to filling their residence with the things that will make life more convenient … and more beautiful. Flooring is no different from other ...

Tags: Flooring Choice, House decor

U.S. Allergists Say a New Long-Term Medication in Under-The-Tongue Tablet

Dec 15, 2013

U.S. allergists say a new long-term medication in under-the-tongue tablet form is promising and may even have the potential to cure hay fever. Officials at the American Academy of Allergy, Asthma & Immunology said allergy immunotherapy is ...

Tags: Health, Medicine

Stallergenes, DBV Entered Into an Agreement for Treatment of Birch Allergy

Oct 22, 2013

France-based biopharmaceutical firms Stallergenes and DBV Technologies have entered into a research and development agreement for the treatment of birch allergy. Stallergenes is specialized in the manufacturing of immunotherapy medicines ...

Tags: Birch Allergy Products, Stallergenes

NDAC Has Recommended Approval of Sanofi's Nasacort AQ Nasal Spray

Aug 2, 2013

The US FDA Nonprescription Drugs Advisory Committee (NDAC) has recommended approval of Sanofi's Nasacort AQ nasal spray (triamcinolone acetonide) for over-the-counter use in the country. Nasacort AQ Nasal Spray is indicated to treat the ...

Tags: Nasacort AQ Nasal Spray, Medicine

Nuvo Research Has Received US Patent Relating to Compositions and Methods of Using WF10

May 17, 2013

Canada-based pharmaceutical company Nuvo Research has received US Patent relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis and atopic dermatitis. ...

Tags: Nuvo Research, Drug Candidate

FDA Acceptance of Biologics License Application Sublingual Allergy Immunotherapy Tablet

May 13, 2013

Merck, referred to as MSD outside the US and Canada, has announced the FDA acceptance of biologics license application (BLA) of investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet for review. ...

Tags: Merck Biologics, Medicine

Meda Pharmaceuticals Has Announced The Availability of Nasal Spray Formulation

May 2, 2013

Meda Pharmaceuticals has announced the availability of nasal spray formulation of fluticasone propionate and azelastine hydrochloride, Dymista, on prescription in the UK. Dymista is indicated for the symptomatic treatment of moderate to ...

Tags: Meda Dymista, Medicine

The US FDA Has Accepted Merck's BLA for an Investigational AIT

Mar 28, 2013

The US FDA has accepted Merck's biologics license application (BLA) for an investigational allergy immunotherapy tablet (AIT), Timothy grass pollen (Phleum pratense). The application includes safety and efficacy data of the ...

Tags: FDA, Merck Bla, Allergy Immunotherapy Tablet

Mhra in The UK Has Granted Marketing Authorization to Dymista

Mar 15, 2013

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization to Meda Pharmaceuticals' nasal spray formulation Dymista for the symptomatic treatment of moderate to severe seasonal and perennial ...

Tags: Meda Pharma, Pharmaceuticals, clinical services

Mylan Has Signed a Settlement and License Agreements with Shionogi and CIMA Labs

Dec 7, 2012

Mylan has signed a settlement and license agreements with Shionogi and CIMA Labs regarding Prednisolone sodium phosphate orally disintegrating tablets (ODT), known generically as Orapred ODT. Mylan said that following the settlement ...

Tags: ODT, orally disintegrating tablets, orapred ODT

Qualitest Has Introduced Generic Version of Singulair Tablets, Chewable Tablets

Nov 29, 2012

Qualitest Pharmaceuticals has introduced generic version of Singulair (montelukast sodium) tablets and chewable tablets and will immediately begin the product shipment. The launch of the Montelukast Sodium Tablets indicated for treating ...

Tags: Generic Singulair Tablets, Chewable Tablets, Endo Health Solutions

Sunovion Pharmaceuticals Has Launched Zetonna Nasal Aerosol in US

Nov 27, 2012

Sunovion Pharmaceuticals has launched Zetonna(ciclesonide)Nasal Aerosol,74 mcg once-daily,in the US,which is used to treat allergic rhinitis(AR),also known as hay fever or nasal allergies. Zetonna is also used to treat symptoms ...

Tags: Sunovion Pharmaceuticals, allergic rhinitis, Zetonna

Sun Pharmaceutical Industries Has Received FDA Approval for Azelastine HCl Nasal Spray

Nov 27, 2012

Sun Pharmaceutical Industries has received FDA approval for its abbreviated new drug application (ANDA) of Azelastine HCL nasal spray, 0.1% (137mcg/spray). The generic equivalent to Medpointe Pharm's Astelin nasal spray is indicated to ...

Tags: Sun Pharmaceutical Industries, Azelastine HCL nasal spray, Medicine

Sunovion Pharmaceuticals Must Release Zetonna Nasal Aerosol for Allergic Rhinitis in US

May 8, 2012

Sunovion Pharmaceuticals is set to launch Zetonna (ciclesonide) nasal aerosol, a non-aqueous, dry nasal aerosol spray for allergic rhinitis in the third quarter of 2012 in the US. The 74mcg once-daily product is indicated for the ...

Tags: Sunovion Pharmaceuticals, Medicine, Zetonna nasal aerosol

allergic rhinitis

Related Products